Antiphospholipid syndrome
1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Insights
Antiphospholipid syndrome causes hypercoagulability, leading to thrombosis and pregnancy issues. Management involves preventive treatments and anticoagulation for affected individuals.
Area of Science:
- Medical Science
- Immunology
- Hematology
Background:
- Antiphospholipid syndrome (APS) is a significant acquired hypercoagulable state.
- Key clinical manifestations include thrombotic events and adverse pregnancy outcomes.
- Diagnosis relies on specific antiphospholipid antibody tests.
Purpose of the Study:
- To provide a comprehensive overview of antiphospholipid syndrome.
- To detail the diagnostic criteria and clinical presentations of APS.
- To outline current management strategies for APS.
Main Methods:
- Review of existing literature on antiphospholipid syndrome.
- Analysis of diagnostic criteria including antiphospholipid antibodies.
- Examination of treatment protocols for APS management.
Main Results:
- APS is characterized by increased blood clot formation.
- Common presentations include arterial, venous, and microvascular thrombosis.
- Pregnancy morbidity encompasses miscarriages, fetal demise, and pre-eclampsia.
Conclusions:
- Accurate diagnosis of APS is crucial for effective management.
- Treatment strategies aim to prevent thrombotic events and improve pregnancy outcomes.
- Long-term anticoagulation is a cornerstone of management post-thrombosis.
Abstract:
Antiphospholipid syndrome is one of the more common acquired causes of hypercoagulability. Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia). Classification criteria include 3 different antiphospholipid antibodies: lupus anticoagulant, anticardiolipin, and anti-beta 2 glycoprotein I. Management includes both preventive strategies (low-dose aspirin, hydroxychloroquine) and long-term anticoagulation after thrombosis.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease IV: Nursing Management
Nephrotic Syndrome I : Introduction


